p#HER#

Related by string. * * p#HER# positive *

Related by context. All words. (Click for frequent words.) 69 carcinoembryonic antigen 68 estrogen receptor ER 67 LHRH receptors 66 Akt activation 66 caveolin 1 66 immunoreactivity 65 ERalpha 65 tumorigenicity 65 HER2/neu 65 vimentin 65 epithelial tumors 65 constitutively active 65 CD# expression [001] 65 HER2 neu 65 lactate dehydrogenase LDH 65 mRNA expression 65 estrogen receptor progesterone receptor 65 p#NTR 65 AGTR1 65 miR #a [001] 65 p# activation 64 IL 1ß 64 TIMP 1 64 promoter methylation 64 bFGF 64 EGFR expression 64 MAGE A3 64 neurite outgrowth 64 HER2 expression 64 CEACAM1 64 imatinib therapy 64 TIMP 64 HER2 ErbB2 64 PC3 cells 64 immunostaining 64 N cadherin 64 HER-2/neu 64 WT1 63 thyroglobulin 63 antitumor efficacy 63 EpCAM 63 c MYC 63 TNFa 63 NKG2D 63 p# mutation 63 tryptase 63 β catenin 63 colorectal carcinoma 63 cytokeratin 63 colorectal adenocarcinoma 63 lymph node metastasis 63 tumoral 63 liver metastases 63 Immunohistochemical analysis 63 effector function 63 transgene expression 63 induces apoptosis 63 RRM1 63 P selectin 63 Ki# 63 HIF 1a 63 IgG4 63 haematopoietic 63 seminomas 63 ERK activation 63 intercellular adhesion molecule 63 K ras mutations 63 TNFalpha 63 TGF ß1 63 ERK1 2 63 ADAMTS# 63 TGF alpha 63 alveolar epithelial cells 63 iNOS 63 HIF 1alpha 62 BRAF V#E mutation 62 osteoblastic 62 AT1R 62 prostate epithelial cells 62 immunohistochemical staining 62 LPS induced 62 IFN gamma 62 PTHrP 62 Clusterin 62 mitogenic 62 S#A# [002] 62 xenograft models 62 CD#c 62 androgen receptor AR 62 colonic mucosa 62 TRAIL R2 62 inducible nitric oxide synthase 62 colorectal carcinomas 62 microglial activation 62 gastric adenocarcinoma 62 immunoreactive 62 cyclin E 62 E selectin 62 telomerase activity 62 catenin 62 carcinoids 62 TTR gene 62 inhibitory effects 62 mutant p# 62 CD# CD# 62 HER2 HER2 61 HIF 1α 61 proapoptotic 61 progesterone receptor negative 61 tNOX 61 extracellular domain 61 BRAF mutation 61 HER2 overexpression 61 FasL 61 microvessel density 61 TOP2A 61 FLT3 61 activating mutations 61 HER2 receptor 61 cisplatin resistant 61 F FDG PET 61 troponin T 61 p#Kip# 61 EGFR HER2 61 lactate dehydrogenase 61 Rap1 61 mesothelin 61 CTGF 61 hCG beta 61 TGF β 61 GLI1 61 HGPIN 61 PC# cells 61 synthase TS 61 hepatoma 61 hypermethylation 61 rhIL 7 61 tumor xenografts 61 metastatic lesions 61 EGFP 61 Immunohistochemical staining 61 tumor necrosis 61 epithelial markers 61 thyrotropin 61 TGF ß 61 B7 H3 61 malignant prostate 61 pCR 61 IGF IR 61 CagA 61 TRAIL R1 61 prostatic tissue 61 constitutively expressed 61 EGFR protein 61 neovasculature 61 EGFRvIII 61 natriuretic peptides 61 lung metastasis 61 PDGFR 61 KRAS mutations 61 lymphoid organs 61 hypoperfusion 61 CCR7 61 precursor lesions 61 micronuclei 61 ALB # 61 SPINK1 61 c Src 61 tissue microenvironment 61 gadolinium enhanced 60 intravascular hemolysis 60 interferon γ 60 constitutively 60 Eg5 60 plasma pharmacokinetics 60 pulmonary metastases 60 biodistribution 60 autophagic 60 immunological responses 60 MMP2 60 antiangiogenic 60 breast carcinomas 60 cellularity 60 thyroid carcinoma 60 HepG2 cells 60 VSV G 60 TGFß 60 VEGF expression 60 KIT mutations 60 FDG uptake 60 hepatocellular carcinomas 60 PECAM 1 60 SLNB 60 antibody titer 60 serum prostate 60 ectopic expression 60 estrogen receptor alpha 60 transfected cells 60 lymphangiogenesis 60 antitumor effects 60 skeletal metastases 60 MT1 MMP 60 TNFR1 60 retinal ischemia 60 cells transfected 60 μmol L 60 lesional 60 E#F# 60 hemoglobin Hb 60 thymidylate synthase TS 60 aminotransferase levels 60 gliosis 60 contractile function 60 RASSF1A 60 ERBB2 60 IL 1beta 60 tumor antigen 60 EGFR receptor 60 microglial 60 VEGFR1 60 echocardiographic parameters 60 TGF beta signaling 60 5alpha reductase 60 MAPK pathway 60 GHRH 60 radiosensitivity 60 MYCN 60 ERK phosphorylation 60 TGF beta1 60 gastric carcinoma 60 HDAC6 60 activin 60 ERCC1 60 neointimal hyperplasia 60 mesangial 60 fibrin deposition 60 TNF α 60 Abeta# 60 IGFBP 3 60 tumor regressions 60 aminotransferases 60 selectively inhibited 59 pancreatic adenocarcinoma 59 tyrosine phosphorylation 59 HER2 receptors 59 chemosensitivity 59 chloride secretion 59 59 CD# + [001] 59 ß amyloid 59 neoplastic cells 59 renal fibrosis 59 transaminases 59 CD1d 59 claudin 59 HER2 amplification 59 IFN α 59 neuroblastoma tumors 59 P cadherin 59 dose dependently 59 factor PlGF 59 PSMA ADC 59 glioma cells 59 p# antigen 59 CYT# potent vascular disrupting 59 Overexpression 59 myeloperoxidase 59 ovarian carcinoma 59 lymphadenopathy 59 ADPKD 59 vasodilatation 59 LHRH receptor 59 leukocytosis 59 GRP# 59 autoregulation 59 Factor Receptor 59 cytoreduction 59 epithelial cell 59 MET amplification 59 prostate carcinoma 59 IL #p# 59 intratumoral 59 NF kappaB activation 59 p tau 59 murine 59 splenic 59 activated lymphocytes 59 ERa 59 microsatellite instability 59 annexin V 59 adrenocortical 59 EGFr 59 hTERT 59 PAOD 59 serum phosphate 59 riociguat 59 factor HGF 59 antigen PSA levels 59 pDCs 59 specific antigen PSA 59 malignant transformation 59 interleukin IL -6 59 urothelial 59 cytokine signaling 59 MMP9 59 Trp p8 59 DLC1 59 IFN γ 59 leukemic cell 59 cMET 59 PBMCs 59 CCR9 59 mutated BRAF gene 59 hepatocellular 59 B7 H4 59 MGd 59 E cadherin expression 59 PSADT 59 μg ml 59 vivo potency 59 OGG1 59 nitrotyrosine 59 eNOS 59 acinar 59 STAT3 signaling 59 tracer uptake 59 TrkA 59 homodimers 59 Lp PLA 2 59 liver metastasis 59 atherosclerotic lesions 59 Symadex 59 MUC1 59 Pin1 59 kidney allograft 59 lytic 59 IDH mutations 59 neurotrophic 59 MLL AF9 59 paclitaxel cisplatin 59 VEGF induced 59 serum cortisol 59 osteosarcomas 59 EGF receptor 59 hCG Beta 59 intestinal mucosa 59 upregulates 59 IL 1β 59 histologically 59 ENMD # 59 Leydig cells 59 parenchymal 59 antiapoptotic 59 urothelial carcinoma 59 hematological parameters 59 VEGF receptor 59 xenograft tumors 59 coexpression 59 vascular endothelial 59 Cytotoxic T 59 cerebral ischemia 59 immunohistochemical 59 whose tumors overexpress 59 intestinal epithelium 58 RQ PCR 58 histone acetylation 58 HAAH 58 IGFBP 58 serum calcium levels 58 myocardial necrosis 58 p# INK4a 58 N. gonorrhoeae 58 prognostic significance 58 clonogenic 58 hyperalgesia 58 Leydig cell 58 lymphocytosis 58 CIN3 58 mutated KRAS 58 GPNMB 58 M1 muscarinic 58 metachronous 58 Bcl xL 58 platelet reactivity 58 ACh 58 hENT1 58 biochemical relapse 58 ErbB 58 HIV RNA 58 astrocytic 58 endothelial nitric oxide synthase 58 PDGF receptor 58 Aurora kinase 58 survivin 58 cyclooxygenase 2 58 SCr 58 degranulation 58 osteolytic 58 colorectal pancreatic 58 transgenic mice expressing 58 ERK signaling 58 ischaemia 58 pharmacodynamic PD 58 deacetylation 58 osteogenic differentiation 58 thyroid peroxidase 58 ErbB2 58 apoptotic cells 58 EphA2 58 isoenzyme 58 anti apoptotic proteins 58 epididymal 58 interferon IFN 58 intact parathyroid hormone 58 ChR2 58 soluble CD# 58 DEAR1 58 heparanase 58 trophoblast cells 58 ALDH 58 gastric mucosa 58 Angiotensin converting enzyme 58 PKC beta 58 thioredoxin 58 scintigraphic 58 somatostatin receptors 58 mPGES 1 58 CTAP# Capsules 58 histologic subtypes 58 uPAR 58 syngeneic 58 glomerular 58 Foxp3 58 annexin 58 sFlt 1 58 glycosylated 58 HBeAg 58 nephrotoxicity 58 pro angiogenic 58 bleomycin 58 upregulating 58 NKX#.# 58 pancreatic endocrine 58 myeloproliferative diseases 58 PSA nadir 58 pyruvate kinase 58 tumor xenograft models 58 colon carcinoma 58 transcriptionally 58 CD8 + 58 urothelium 58 serotonin synthesis 58 metabolic parameters 58 distant metastasis 58 miR #b [001] 58 transfected 58 nanomolar 58 H#K#me# 58 Mesothelin 58 downregulated 58 growth hormone secretion 58 Cyclooxygenase 2 58 Lyn kinase 58 prostate cancer CaP 58 mutated K ras 58 mediated inhibition 58 leukocyte adhesion 58 58 interleukin IL -# 58 ZNF# 58 DNA hypermethylation 58 receptor CXCR4 58 inhibitory receptor 58 lymphocyte counts 58 HBx 58 prostaglandin E 58 plasmacytoid dendritic cells 58 renal cysts 58 cytotoxic effects 58 carcinoembryonic antigen CEA 58 NO synthase 58 erythropoiesis 58 vascularization 58 FOLFOX6 58 dephosphorylation 58 SUVmax 58 hyperphenylalaninemia HPA due 58 costimulatory molecules 58 chromosomal aberrations 58 EGFR inhibitors 58 Jhdm2a 58 node metastases 58 μM 58 antiangiogenic agents 58 HGS ETR2 58 anticancer activity 58 effector functions 58 GSTP1 58 Her2/neu 58 NY ESO 58 HDAC2 58 ventricular tachyarrhythmia 58 HbF 58 SERCA2a 58 endometrial carcinoma 58 neovascularization 58 NSCLC tumors 58 FGFR2 58 MGMT gene 58 antiproliferative effects 58 LV ejection fraction 58 p# biomarker 58 serum TSH 58 LRAT 58 amyloid deposition 58 novel VDA molecule 58 fibrotic disease 58 selective modulator 58 serum HBV DNA 58 Cardiotoxicity 58 prognostic indicator 58 autoantibody levels 58 mu opioid receptor antagonist 57 NFKBIA 57 motoneurons 57 LNCaP cells 57 monocytes macrophages 57 endoglin 57 keratinocyte 57 myocyte 57 Jurkat cells 57 cell adhesion molecule 57 synovial tissue 57 CIN2 + 57 penetrance 57 ischemia induced 57 IFN beta 57 protein tyrosine phosphatase 1B 57 microvascular endothelial cells 57 Fibroblast 57 ABCB1 57 peptide antigens 57 Epidermal Growth Factor Receptor 57 murine model 57 CDK8 57 RAR beta 57 metastatic malignant 57 inotropic 57 carotid IMT 57 mouse xenograft models 57 cAMP signaling 57 TroVax ® 57 p# MAPK 57 HER2 negative 57 alanine aminotransferase ALT 57 castrate resistant 57 PTPN# 57 creatinine ratio 57 hypomethylation 57 collagen degradation 57 complete cytogenetic response 57 fibrinolysis 57 hyperactivated 57 Granulocyte Colony Stimulating Factor 57 neovascular 57 p#INK#a 57 chemokine receptors 57 pAkt 57 cardiac myocytes 57 CD# upregulation 57 cytolytic 57 multivariable analysis 57 GATA3 57 vasodilation 57 virologic responses 57 aberrantly activated 57 serum PTH 57 corticosteroid dexamethasone 57 transgenic rats 57 microtubule dynamics 57 gene rearrangements 57 FGF2 57 proteoglycan 57 Cx# [001] 57 plasma leptin 57 oncoprotein 57 vitro cytotoxicity 57 premalignant lesions 57 immunomodulation 57 MS relapses 57 serum albumin 57 plasma fibrinogen 57 IGF1R 57 melanocyte 57 RhoA 57 cardiac troponin 57 HuR 57 Bezielle 57 MyoD 57 transcriptional activation 57 monocyte chemoattractant protein 57 pmol L 57 Fas ligand 57 intracranial hemorrhage ICH 57 baseline LDH 57 pretransplant 57 Monocyte 57 agonist induced 57 vWF 57 BMPR2 57 gastrointestinal stromal tumors GISTs 57 occludin 57 IL #R 57 metalloproteinase 57 NAbs 57 prostaglandin synthesis 57 choroid 57 EZH2 57 beta1 integrin 57 receptor activation 57 trastuzumab Herceptin ® 57 Endothelial dysfunction 57 cathepsins 57 cyclin B1 57 perfusion defects 57 histological subtypes 57 serum concentrations 57 SGPT 57 alanine aminotransferase 57 CsA 57 Sgk1 57 LHRH 57 CCL# 57 fibrosis progression 57 bronchoalveolar lavage 57 lupus anticoagulant 57 T1 weighted images 57 CYP#B# 57 transthyretin 57 MDR1 57 P#Y# [002] 57 CD# antigen 57 HNSCC 57 depsipeptide 57 virological response 57 trabecular 57 nAChR 57 adipogenic 57 mitochondrial respiration 57 PTEN protein 57 systemic toxicity 57 CD# protein 57 malignant ascites 57 intimal hyperplasia 57 SOCS3 57 Nod1 57 GABAergic interneurons 57 IGF 1R 57 intraventricular 57 proteolytic cleavage 57 LHRH receptor positive 57 c Fos 57 SOD1 gene 57 retransplantation 57 brain lesions 57 PTH secretion 57 airway epithelium 57 replicon 57 Neisseria gonorrhoeae 57 triiodothyronine 57 Natalizumab 57 luteinizing hormone releasing 57 breast epithelial cells 57 pathologic diagnosis 57 Lymph node 56 Cyclin D1 56 airway hyperresponsiveness 56 axonal regeneration 56 HBsAg 56 busulfan 56 telomere lengths 56 osteoblast 56 histologic subtype 56 thymic 56 enzymatic activity 56 polymorphonuclear 56 cytopenias 56 nucleolin 56 oncogenic transformation 56 hepatic arterial 56 cyclic AMP cAMP 56 HIF PH inhibitors 56 downregulating 56 SSc 56 macrophage infiltration 56 CCR2 56 mTOR inhibition 56 immunostimulatory 56 demonstrated antitumor activity 56 TLE3 56 Transgenic Mice 56 CD#L 56 fluid secretion 56 sunitinib Sutent 56 receptor tyrosine kinase 56 symptomatic VTE 56 tumor perfusion 56 EBNA1 56 thrombus formation 56 P#X# receptors 56 Interferon Beta 56 neutrophil infiltration 56 V#F 56 bladder carcinoma 56 colorectal gastric 56 antibody titers 56 tumors GIST 56 lysyl oxidase 56 alpha folate receptor 56 adenoviral 56 thymidine kinase 56 ovarian hormones 56 T#I [002] 56 progesterone receptors 56 leukaemias 56 phosphoprotein 56 esophageal carcinoma 56 myocytes 56 stage IIIb IV 56 FUS1 56 rCBF 56 CanAg 56 CD#b 56 cardiac repolarization 56 MEK1 56 metastatic neuroendocrine tumors 56 serous ovarian cancer 56 extrahepatic 56 MGUS 56 alkaline phosphatase 56 PHD2 56 mg kg dose 56 motor neuron degeneration 56 TLR2 56 FOXP3 56 CXCL5 56 immune reconstitution 56 HCV replicon 56 multiple myeloma MM 56 neurturin 56 eIF 4E 56 TRAIL Receptor 56 triacylglycerol 56 RIP1 56 pT3 56 glomerular filtration 56 leukemia AML 56 nodal metastasis 56 HER2/neu protein 56 HBeAg seroconversion 56 EGFR signaling 56 circulating lymphocytes 56 membrane permeability 56 redox active 56 osteoclast 56 epithelial cells lining 56 potentiation 56 autocrine 56 edifoligide 56 FGFR4 56 TET2 56 TXNIP 56 thyrotropin levels 56 nonmetastatic 56 Gleevec resistant 56 recurrent glioblastoma multiforme 56 virologic response 56 ventricular myocardium 56 STAT1 56 adrenocorticotropic hormone ACTH 56 poly ADP ribose polymerase 56 GIST tumors 56 PKCi 56 vidofludimus 56 paxillin 56 intrahepatic 56 monomeric 56 substrate specificity 56 protein tyrosine phosphatase 56 BH4 56 serum aminotransferase levels 56 androgen receptor signaling 56 ventricular remodeling 56 carcinoma HCC 56 β cell 56 cardiac contractility 56 DNMT1 56 BCR ABL protein 56 Treg cell 56 leukocyte counts 56 systolic function 56 alvespimycin 56 specific lectin receptors 56 hematologic toxicity 56 hypermethylated 56 parathyroid hormone PTH 56 Dystrophin 56 clonal expansion 56 myofibroblast 56 microvessel 56 vaso occlusive crisis 56 NS#/#A protease 56 eosinophilia 56 pancreatic lung 56 platelet activation 56 downregulation 56 prostate adenocarcinoma 56 hormone receptor negative 56 TNFα 56 pseudoaneurysm 56 BCR ABL mutations 56 leiomyomas 56 HBeAg negative 56 adrenal function 56 menadione 56 Androgen 56 aspartate aminotransferase 56 C1q 56 antitumor effect 56 alkaline phosphatase ALP 56 mucosal inflammation 56 Adjuvant Treatment 56 antisense inhibition 56 bladder ovarian 56 FoxP3 56 aminotransferase 56 cytopathic 56 PEDF 56 genotypic resistance 56 Bcl XL 56 HUVEC 56 Upregulation 56 resected pancreatic cancer 56 XL# inhibits 56 metaplasia 56 IL#B 56 PAX5 56 Vidofludimus 56 cyclooxygenase 56 antibody mediated 56 JAK2 enzyme 56 leukocyte infiltration 56 lung epithelium 55 MEK ERK 55 metastatic prostate 55 hA# 55 adenocarcinomas 55 infarcts 55 histologic findings 55 frataxin 55 BH3 55 Her-2/neu 55 AST ALT 55 overactivation 55 EGFR TKI 55 R0 resection 55 pancreatic ovarian 55 P#X# 55 targeting CD# 55 NMDAR 55 aurora kinase 55 chemoresistant 55 glutamate neurotransmission 55 BCL#A 55 IGFBP7 55 K + ATPase 55 histological subtype 55 breast cancer subtypes 55 somatostatin 55 advanced adenomas 55 artery stenosis 55 HBV DNA levels 55 methionine aminopeptidase 55 grade cervical intraepithelial 55 Pharmacokinetics PK 55 suppressor gene 55 cortical excitability 55 β amyloid 55 cardiac dysfunction 55 siRNA mediated 55 Beta catenin pathway 55 SHANK3 55 NQO1 55 radiographic progression 55 MMP# 55 cytochrome P 55 renal allograft 55 proinflammatory 55 leukemic stem cells 55 hemorrhagic complications 55 antiangiogenic agent 55 PSMA protein 55 plasma folate 55 IRE1 55 prostatic 55 seropositivity 55 tumor histology 55 metastatic melanomas 55 Macrophage 55 HOTAIR 55 demyelination 55 oral prodrug 55 recurrent ovarian 55 cis retinoic acid 55 untreated metastatic melanoma 55 castration resistant 55 adjuvant cisplatin 55 CYP#A# CYP#D# 55 serum clusterin levels 55 F FDG uptake 55 neutrophil counts 55 lymphoid malignancies 55 contractile muscle 55 atheroma volume 55 PIGF 55 glycosylated hemoglobin levels 55 systemically administered 55 HuLuc# 55 osteoclast activity 55 Disease Progression 55 plasminogen activator inhibitor 55 TUNEL 55 hepatocyte 55 lumbar spine BMD 55 Th2 cytokines 55 Rb#/p# 55 cerebral vasospasm 55 liposomal doxorubicin 55 mucociliary clearance 55 COX2 55 infarct size 55 KRAS status 55 OMP #M# 55 HER2 positive cancers 55 elevated creatinine 55 CD# molecule 55 Alu RNA 55 atypical ductal hyperplasia 55 ß1 55 nonalcoholic steatohepatitis NASH 55 receptor tyrosine kinase inhibitor 55 transcriptional silencing 55 pelvic lymphadenectomy 55 DACH platinum 55 sarcosine 55 nucleotide analog 55 choroidal neovascularization 55 polycythemia vera essential thrombocythemia 55 CD8 responses 55 goserelin 55 platelet aggregation 55 proteolysis 55 pathophysiological effects 55 cyclic adenosine monophosphate cAMP 55 microcirculatory 55 prostaglandin E2 55 BRCA deficient 55 allergic inflammation 55 inhibitor COX 55 leukocyte count 55 intima media thickness 55 cis RA 55 microRNA miR 55 azacytidine 55 recurrent metastatic 55 FGFR1 55 hepatic enzymes 55 choroidal neovascularization CNV 55 apolipoprotein B 55 mutated p# 55 natriuresis 55 IMC A# 55 Prolactin 55 proinflammatory cytokines 55 ApoA1 55 hepatic lesions 55 granulocyte 55 Angiotensin II 55 lysophosphatidic acid LPA 55 PPARg 55 uM 55 pulmonary infiltrates 55 Nampt 55 glucocorticoid 55 CLL SLL 55 Vidaza azacitidine 55 KRAS mutation 55 huC# DM4 55 K#N

Back to home page